Navigation Links
Methylphenidate 'normalizes' activation in key brain areas in kids with ADHD
Date:5/9/2013

Philadelphia, Pa. (May 9, 2013) The stimulant drug methylphenidate "normalizes" activation of several brain areas in young patients with attention-deficit/hyperactivity disorder (ADHD), according to a review published in the May Harvard Review of Psychiatry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Studies using functional magnetic resonance imaging (fMRI) show increased activation of key brain areas after a dose of methylphenidate in young patients with ADHD, according to the systematic review by Constance A. Moore, PhD, and colleagues of the University of Massachusetts Medical School. They write, "In most cases, this increase 'normalized' activation of at least some brain areas to levels seen in typically developing children."

How Do ADHD Medications Affect the Brain in ADHD Patients?

In a research review, Dr Moore and colleagues identified nine previous studies using fMRI to study patterns of brain activation in response to a single dose of methylphenidate. Perhaps best known by the brand name Ritalin, methylphenidate is a common and effective treatment for ADHD. "Although methylphenidate has been shown to significantly improve the behavioral symptoms associated with ADHD, both the mechanism behind its therapeutic effect and its direct effects on brain function are unknown," the researchers write.

The studies evaluated methylphenidate-induced fMRI changes in various brain areas, as the participants performed different types of tasks. Most of the studies included adolescent boys with ADHD, along with matched groups of young people without ADHD.

Methylphenidate altered activation patterns in widely distributed areas of the brain in ADHD patients, the results showed. The main brain areas involved were the frontal lobes, the basal ganglia, and cerebellum: "Abnormalities in these regions have all been implicated in patients with ADHD," Dr Moore and coauthors write.

Different areas were activated during different types of fMRI tasks. Several studies assessed performance on "inhibitory control" tasksthe ability to control certain types of accustomed ("prepotent") responses. In three out of five studies, methylphenidate "at least partially normalized" brain activation in ADHD patients, compared to healthy young people.

Different Tasks Affect Different Brain Areas

A few studies showed similar normalization of brain responses with methylphenidate on tasks of selective attention and time perceptionalthough not on tasks evaluating working memory. Methylphenidate mainly affected activation in the frontal lobes during inhibitory control tasks. During selective attention tasks, a wider range of brain areas were affected.

Since none of the studies evaluated ADHD symptoms on and off methylphenidate, there was no way to link the changes in brain activation with clinical improvement. Brain activation patterns with methylphenidate differed for patients who were versus were not previously treated with stimulants for ADHD.

Patients with ADHD have "age-inappropriate frequency or severity of inattentive or hyperactive-impulsive behaviors," according to the authors. It affects about five percent of children worldwide, and a growing body of evidence suggests that ADHD persists throughout adolescence and into adulthood. Functional fMRI provides a safe, noninvasive way to study how stimulants like methylphenidate may act in the brain of ADHD patients.

The new analysis suggests that methylphenidate partially normalizes activation in key brain areas thought to be involved in ADHD. The studies "may provide evidence that methylphenidate facilitates the return of brain function in ADHD patients to, or close to, a typically functioning state," Dr Moore and colleagues write. They call for further research to confirm that methylphenidate-induced changes in specific brain areas are correlated with improvement in ADHD symptoms.


'/>"/>

Contact: Connie Hughes
connie.hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health
Source:Eurekalert

Related medicine news :

1. Girls with eating disorders regain healthy fatty acid levels when their weight normalizes
2. Research reveals new understanding of X chromosome inactivation
3. HPV in older women may be due to reactivation of virus, not new infection
4. Same protein that fires up cancer-promoting Erk also blocks its activation
5. Study Suggests Vaccine May Help Kids With Brain Cancer
6. Epilepsy Leads to More Brain Abnormalities Over Time
7. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
8. Why is traumatic brain injury increasing among the elderly?
9. Brain Falters Near End of Life, but Games, Puzzles Might Slow Decline
10. Dental X-Rays May Be Linked to Benign Brain Tumors
11. Nonsurgical Method to Measure Brain Pressure Shows Promise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, a ... cells and other difficult to transfect cells, announces its launch of the PluriQ™ ... Gene Editing System is a complete system for culturing and transfecting human ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American ... function testing company, is now able to perform sophisticated lung assessments ... ndd Medical Technologies , Inc. Patients are no ...  Thanks to ndd,s EasyOne PRO ® , ARL patients like Jeanne ... needed testing done in the comfort of her own home. ...
Breaking Medicine Technology: